BackGeovax Labs- Warrants (01/01/2025) Overview

Geovax Labs- Warrants (01/01/2025) Accounts Payable

Track Geovax Labs- Warrants (01/01/2025)'s accounts payable ($1.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.83M
0.22% YoYΔ $4097.00 vs prior year quarter

Peer trimmed avg / median

Loading

Geovax Labs- Warrants (01/01/2025) Accounts Payable History

Loading

Geovax Labs- Warrants (01/01/2025) vs. peers: Accounts Payable Comparison

Loading

Geovax Labs- Warrants (01/01/2025) Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Geovax Labs- Warrants (01/01/2025) (GOVXW) FAQ

As of the most recent data (June 2026), GOVXW shows a accounts payable of $1.8M. That compares with $1.8M in the prior-year period — up 0.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GOVXW's accounts payable is now $1.8M (was $1.8M) — a 0.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Geovax Labs- Warrants (01/01/2025) is outperforming or lagging.

Tracking GOVXW's accounts payable over time shows whether Geovax Labs- Warrants (01/01/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8M That compares with $1.8M in the prior-year period — up 0.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Geovax Labs- Warrants (01/01/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.8M) with ownership activity and broader fundamentals.

Geovax Labs- Warrants (01/01/2025)'s accounts payable is $1.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.